There were 1.5 million people living with HIV in Kenya in 2016. Only 59% of adults living with HIV are on antiretroviral treatment. Infections are particularly high among marginalised groups such as men who have sex with men (MSM), sex workers and people who use drugs.

We partner with KANCO, a network of indigenous Kenyan organisations working not just on the HIV response, but across public health care in Kenya. KANCO works to strengthen its member organisations, improve community responses to HIV, and integrate HIV and TB services. In 2016, KANCO provided over 30,000 people living with HIV and TB with support in the form of integrated services.

In Kenya, there are an estimated 18,000 people who inject drugs. Through the Community Action on Harm Reduction programme, KANCO implemented Kenya’s first ever needle and syringe exchange and methadone replacement programme. KANCO are continuing this work as the principal recipient for the Global Fund Regional Grant for Harm Reduction in Eastern Africa. They are also working on the Alliance’s Integrated Harm Reduction Programme, and provided 10,518 people who use drugs with prevention services in 2016.

KANCO was also a partner in the multi-country SHARP programme, which improved the sexual health and rights of MSM in Tanzania, Uganda and Zimbabwe. Although this programme has ended, KANCO provided 21,889 people with integrated HIV and SRHR services in 2016. KANCO are also partners on the PITCH programme, which aims to develop the capacity of civil society organisations to advocate for improved access to HIV prevention, care and treatment services.